News
CDC: No Restrictions Needed for Johnson & Johnson Coronavirus Vaccine, Panel Advises US Resume Use

The Centers for Disease Control and Prevention late Friday afternoon announced a CDC panel has determined no restrictions are necessary on the Johnson & Johnson coronavirus vaccine, and advised use of the vaccine be resumed. CDC halted use of the vaccine temporarily amid reports of six cases of blood clots in women 18 to 48 years old.
“The recommendation, which was adopted 10-4 with one abstention, by the CDC’s Advisory Committee on Immunization Practices, will pave the way for U.S. regulators to lift their recommended pause on using the J&J shot as early as this weekend,” CNBC reports. “The single shot is a critical tool in getting lifesaving vaccines to hard-to-reach places that may not have reliable refrigeration, such as tribal lands, poorer neighborhoods and rural communities, as well as to people who may not be able to come back for a second dose, U.S. health officials say.”
The rate of vaccination in the U.S. dropped dramatically over the past week, by 11%, as health care experts work to reduce vaccine hesitancy.
Anti-science groups on Facebook, and lawmakers like Sen. Ron Johnson (R-WI) are being blamed for extending the pandemic and allowing the coronavirus time to mutate.
This is a breaking news and developing story.
Enjoy this piece?
… then let us make a small request. The New Civil Rights Movement depends on readers like you to meet our ongoing expenses and continue producing quality progressive journalism. Three Silicon Valley giants consume 70 percent of all online advertising dollars, so we need your help to continue doing what we do.
NCRM is independent. You won’t find mainstream media bias here. From unflinching coverage of religious extremism, to spotlighting efforts to roll back our rights, NCRM continues to speak truth to power. America needs independent voices like NCRM to be sure no one is forgotten.
Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure NCRM remains independent long into the future. Support progressive journalism with a one-time contribution to NCRM, or click here to become a subscriber. Thank you. Click here to donate by check.
![]() |